Oxford University Press, Clinical Infectious Diseases, 10(70), p. 2228-2230, 2019
DOI: 10.1093/cid/ciz895
Full text: Unavailable
Abstract The San Diego Early Test score is a simple risk-assessment tool for acute, and early human immunodeficiency virus (HIV) infection. Validation in a prospective cohort of Amsterdam men who have sex with men showed fair prediction of HIV seroconversion (AUC, 0.701). This score can help prioritize and target HIV-prevention strategies.